Genetically Modified Recombinant Human Interleukin-11

interleukin-11 · Beijing Northland Biotech. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genetically Modified Recombinant Human Interleukin-11, covering 2020-09-16 to 2020-09-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11 [Phase 3]

See pricing